Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 904.00 | 782.75 | 1.1549 | 1.2362 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 320.09 | 1003.00 | 782.75 | 1.2814 | 1.4238 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 625.00 | 320.09 | 327.00 | 782.75 | 0.4178 | 0.0167 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 810.00 | 782.75 | 1.0348 | 1.0538 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 959.00 | 782.75 | 1.2252 | 1.3410 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 625.00 | 320.09 | 280.00 | 782.75 | 0.3577 | -0.0985 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 897.00 | 782.75 | 1.1460 | 1.2228 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 734.00 | 782.75 | 0.9377 | 0.9028 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 777.00 | 782.75 | 0.9927 | 0.9886 |
| BT-20 | Lapatinib | 1 | uM | 9 | 625.00 | 320.09 | 739.00 | 782.75 | 0.9441 | 0.9128 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 552.00 | 782.75 | 0.7052 | 0.5256 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1601.00 | 1721.75 | 0.9299 | 0.8937 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1652.00 | 1721.75 | 0.9595 | 0.9388 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1543.00 | 1721.75 | 0.8962 | 0.8419 |
| BT-20 | Linsitinib | 10 | uM | 9 | 1250.00 | 684.27 | 1394.00 | 1721.75 | 0.8096 | 0.7066 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1805.00 | 1721.75 | 1.0484 | 1.0722 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 1434.00 | 1721.75 | 0.8329 | 0.7433 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1832.00 | 1721.75 | 1.0640 | 1.0955 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 684.27 | 1732.00 | 1721.75 | 1.0060 | 1.0089 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1975.00 | 1721.75 | 1.1471 | 1.2172 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 1250.00 | 684.27 | 1913.00 | 1721.75 | 1.1111 | 1.1647 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2007.00 | 1721.75 | 1.1657 | 1.2441 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1892.00 | 1721.75 | 1.0989 | 1.1468 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 684.27 | 1994.00 | 1721.75 | 1.1581 | 1.2332 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1687.00 | 1721.75 | 0.9798 | 0.9696 |